University of Manchester 2017. Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors. WO/2017/017469. [Patent]. |
Official URL: https://patentscope.wipo.int/search/en/detail.jsf?...
Abstract
Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 β activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.
Item Type: | Patent |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Biosciences |
Publisher: | WO Patent |
Last Modified: | 23 Oct 2022 13:13 |
URI: | https://orca.cardiff.ac.uk/id/eprint/110005 |
Actions (repository staff only)
![]() |
Edit Item |